Cite
Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
MLA
Kapczynski, Darrell R., et al. “Efficacy of Recombinant H5 Vaccines Delivered in Ovo or Day of Age in Commercial Broilers against the 2015 U.S. H5N2 Clade 2.3.4.4c Highly Pathogenic Avian Influenza Virus.” Virology Journal, vol. 20, no. 1, Dec. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12985-023-02254-1.
APA
Kapczynski, D. R., Chrzastek, K., Shanmugasundaram, R., Zsak, A., Segovia, K., Sellers, H., & Suarez, D. L. (2023). Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus. Virology Journal, 20(1), 1–10. https://doi.org/10.1186/s12985-023-02254-1
Chicago
Kapczynski, Darrell R., Klaudia Chrzastek, Revathi Shanmugasundaram, Aniko Zsak, Karen Segovia, Holly Sellers, and David L. Suarez. 2023. “Efficacy of Recombinant H5 Vaccines Delivered in Ovo or Day of Age in Commercial Broilers against the 2015 U.S. H5N2 Clade 2.3.4.4c Highly Pathogenic Avian Influenza Virus.” Virology Journal 20 (1): 1–10. doi:10.1186/s12985-023-02254-1.